Data for: Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK

This dataset draws on pharmaceutical company disclosures of payments made to patient organisations in 2012-2016. It contains the transparency variables that apply to our manuscript: Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK. It includes three tabs. 1) The availability of disclosures for each pharmaceutical company, 2) a list of all disclosed payments to patient organisations and their performance on our transparency indicators, 3) a list of excluded payments and the reasons for exclusion.本数据集基于2012至2016年制药企业披露的面向患者组织的支付款项信息，包含适配本研究稿件的透明度相关变量，该研究稿件主题为《评估英国制药企业向患者组织披露支付款项的透明度》。数据集共包含三个数据表标签页：1. 各制药企业披露信息的可获取情况；2. 所有已披露的面向患者组织的支付款项清单，以及各款项在本研究透明度指标下的表现；3. 被排除的支付款项清单及对应的排除理由。